In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines
2013 · Radiation Oncology · 42 citations
https://doi.org/10.1186/1748-717x-8-246
T
Tim Lautenschlaeger
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
171
Papers
1.8K
Citations
20
h-index
30
i10-index
Tim Lautenschlaeger is an academic researcher from Indiana University Health. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Lung Cancer Diagnosis and Treatment & Brain Metastases and Treatment. The author has an h-index of 20, co-authored 146 publications.
Papers by this author
worksLymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy
2022 · Advances in Radiation Oncology · 23 citations
https://doi.org/10.1016/j.adro.2022.100959
Superior vena cava syndrome in a patient with locally advanced lung cancer with good response to definitive chemoradiation: a case report
2018 · Journal of Medical Case Reports · 17 citations
https://doi.org/10.1186/s13256-018-1843-4
Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung Cancer
2021 · Frontiers in Oncology · 7 citations
https://doi.org/10.3389/fonc.2021.599719
Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer
2024 · International Journal of Radiation Oncology*Biology*Physics · 6 citations
https://doi.org/10.1016/j.ijrobp.2024.09.050
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat